logo

Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 10-07-2019
AUM:

₹ 694.5 Cr

Expense Ratio

2.37%

Benchmark

S&P BSE Healthcare TRI

ISIN

INF209KB1O09

Minimum Investment

1000.0

Minimum Topup

1000.0

Minimum SIP Amount

1000

Fund Manager

Dhaval Shah, Dhaval Joshi

Fund Performance 1Y (%) 3Y (%) 5Y (%)
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW 52.08 13.0 -
S&P BSE Healthcare TRI 52.5 14.07 21.99
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
19.84
Last change
-0.03 (-0.1512%)
Fund Size (AUM)
₹ 694.5 Cr
Performance
21.44% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.

Fund Manager
Dhaval Shah, Dhaval Joshi
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
Sun Pharmaceutical Industries Ltd. 14.84
Cipla Ltd. 7.83
Torrent Pharmaceuticals Ltd. 7.41
Apollo Hospitals Enterprise Ltd. 6.33
Others 4.86
Fortis Healthcare Ltd. 4.59
Zydus Lifesciences Ltd. 4.25
Ajanta Pharma Ltd. 4.16
Aurobindo Pharma Ltd. 4.01
Lupin Ltd. 3.89

Sector Allocation

Sector Holdings (%)
Healthcare 91.77
Others 4.72
Insurance 2.01
Services 1.05
Chemicals 0.45